Application Study Of The Clinical Pathway In Uterine Fibroids Treatment

Nowadays, there are much increasing fierce competition in the medical market. It's our mission to find a kind of working mode, which can improve the health care quality and efficiency, reduce expenditure and cost, This working mode could serve as the more reasonable and effective one health resources, as well as perform a better social function of the hospital and improve the cost-effective mode.Clinical Pathway (CP), an advanced management mode, prescribes the range of medicine and medical examinations utilized, so as to achieve the purpose of the use of reasonable medicine and medical check, the control of medical fee and the avoidance of the waste of medical resources. Single disease clinics in the course of the application of Clinical Pathway is probably relatively effective ways and means.Uterine Fibroids of female genital mutilation is the most common benign tumor, is commonly found in human tumors, one of the current incidence of uterine fibroids showed an upward trend year after year. Laparoscopic myomectomy is an effective treatment method of uterine fibroids, one of its minimally invasive, relatively safe, effective, and patients become quick Hysteromyoma an important means of treatment. At present, many hospitals have to laparoscopic myomectomy patients for clinical research and to explore the path, but the lack of unified norms and patterns, which inevitably exists the ability to work due to personal and business level differences caused by differences . Learn at home and abroad in recent years the subject of clinical study on the path of ideas, methods and results of clinical pathway to explore the feasibility of carrying out an effort in the shortest possible time to adapt to our hospital medical and health status of the existing clinical pathway, to be adopted for future clinical pathway mode of disease for reference and guidance for the clinical pathway in the sections and the implementation of a full-house to lay a foundation.This study of laparoscopic surgery patients Uterine Fibroids mode of implementation of Clinical Pathway, patient observation time, hospital costs, post-operative complications and negative effects, as well as patient satisfaction in areas such as evaluation, so as to assess the quality of medical care To further enhance the quality of medical care services to provide a basis of continuous quality improvement and methods.In this study, the Second Hospital of Jilin University collection gynecological ~ January 2008 admitted in December 2008 in line with the 80 cases of uterine myoma laparoscopic surgery the standard of the patients, the number of random sampling method was adopted into Clinical Pathway group (experimental group) and conventional group (control group) 40 cases each. Clinical Pathway established by the Department of the Steering Group and Implementation Group, in accordance with the characteristics and treatment of diseases of the methods and content, extensive literature review and information, the full evidence-based, expert evaluation, according to the southeast United States in 1997 to develop clinical nursing surgery table standard path, to develop the most appropriate standardization, the process of clinical nursing and clinical care path table table patient version of the path. Standard-setting days, inspection, treatment, care, etc., the experimental group using the clinical path of patients in the control group of patients using conventional method, and patient satisfaction surveys. Through the study of statistical methods statistical analysis results. SPSS13.0 all data are used for statistical analysis software package, using t test measurement data;Ð¥2 test the use of count data. Two groups of patients in age, condition, education, urban and rural areas the proportion of comparison, no significant difference (P>0.05), comparable. length of stay in hospital compared two groups of patients using t tests, the experimental group before the waiting time for patients is less than the control group significantly (P<0.05), experimental group patients recovered significantly less than the control group (P<0.01), the experimental group patient The total time was less than the control group (P<0.01), prompted the implementation of the management of Clinical Pathways, patient length of stay shortened significantly. Cost comparison of patient groups using t tests, the experimental group not only the total hospitalization costs of patients is less than the control group significantly (P<0.05). The results further show that two groups of patients, total hospitalization cost difference is mainly due to drugs in experimental group patients (P<0.05) and disposal costs (P<0.05) significantly less than the control group, suggesting that implementation of clinical path management, the patient's hospital fees significantly reduced. Experimental group of patients using analgesics than the control group significantly ( P<0.05 ) Prompt implementation of clinical path management, the use of analgesics in postoperative patients with a significant reduction in the situation. Indicators of postoperative recovery of patients were compared using t tests, the experimental group of patients to get out of bed the first time, the first exhaust time, postoperative functional exercise time, the first time, eating time, after time has returned to normal body temperature is less than the control group (both P<0.01). Prompt implementation of clinical path management, to accelerate postoperative recovery of patients. Experimental group patients the incidence of back pain was significantly lower than the control group, with statistical significance (P<0.01). Experimental group occurred in patients with bleeding, postoperative hematoma formation, abdominal distension and the incidence of infection is also lower than the control group, but no statistical significance(all P>0.05). To assess the situation with the patient in line with the rate of diagnosis of the situation with the patient in line with the rate of patients was significantly higher than the experimental group (both P<0.05), the two groups compared the quality of patient care of patients was significantly higher than the experimental group (both P<0.01), prompt implementation of clinical path management, can improve the quality of medical care. Patient health education awareness group comparison of the experimental group was significantly higher than that of patients (all P<0.05), there are significant differences. Prompt implementation of clinical path management, can improve the effectiveness of health education.The results show that the application of Clinical Pathways, you can receive the following results:First of all, the effective date to shorten the average length of stay, reduce the average length of stay costs, reduce patient burden and increase the number of beds and units, working single-cycle host disease patients; Secondly, standardized treatment processes and realize the standardization of health care activities and procedures;Thirdly, implement evidence-based medicine, as well as "people-oriented, patient-centered" concept, to select the best model of clinical work;Fourthly, to meet patients on their rights, the establishment of the initiative - co-operation-based medicine, nursing, patient relationship and promote mutual exchanges and raise the confidence and satisfaction;Fifthly, to promote the continual improvement of the quality of medical care. Clinical Pathway has been a mature method in foreign countries, for it can both guarantee the quality of nursing and cut down the medical nursing cost, thus promoting the management mode. Through the path of implementation, bottlenecks can be found in the course of treatment, as well as running of the hospital system and service concept put forward a new request, the need for hospital administrators, department leaders, medical personnel and medical technicians assisted the coordination of departments, cooperation and support. there are still many questions concerning Clinical Pathway to be considered and solved. The continual betterment and practice of Clinical Pathway still have a long way to go.